HB Fuller Co (NYSE:FUL) Director Sant R. William Van Sells 10,000 Shares of Stock

HB Fuller Co (NYSE:FUL) Director Sant R. William Van sold 10,000 shares of the stock in a transaction on Thursday, November 7th. The shares were sold at an average price of $51.67, for a total value of $516,700.00. Following the sale, the director now directly owns 7,665 shares in the company, valued at $396,050.55. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink.

HB Fuller stock opened at $51.55 on Friday. The company has a debt-to-equity ratio of 1.77, a current ratio of 2.36 and a quick ratio of 1.55. HB Fuller Co has a one year low of $39.22 and a one year high of $52.18. The stock has a market capitalization of $2.64 billion, a PE ratio of 17.18, a price-to-earnings-growth ratio of 1.67 and a beta of 1.57. The business’s fifty day moving average is $47.89 and its 200 day moving average is $45.89.

HB Fuller (NYSE:FUL) last announced its earnings results on Wednesday, September 25th. The specialty chemicals company reported $0.86 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.90 by ($0.04). The firm had revenue of $725.38 million during the quarter, compared to analysts’ expectations of $749.18 million. HB Fuller had a return on equity of 13.20% and a net margin of 4.78%. The company’s revenue for the quarter was down 5.8% on a year-over-year basis. During the same period in the previous year, the business posted $0.86 earnings per share. As a group, sell-side analysts expect that HB Fuller Co will post 3 EPS for the current fiscal year.

The company also recently announced a quarterly dividend, which was paid on Thursday, October 31st. Shareholders of record on Thursday, October 17th were given a $0.16 dividend. The ex-dividend date was Wednesday, October 16th. This represents a $0.64 annualized dividend and a yield of 1.24%. HB Fuller’s payout ratio is 21.33%.

Several research firms recently commented on FUL. Citigroup cut HB Fuller from a “neutral” rating to a “sell” rating and dropped their price objective for the company from $48.00 to $41.00 in a research report on Friday, September 27th. Zacks Investment Research cut HB Fuller from a “hold” rating to a “strong sell” rating in a research report on Tuesday, October 1st. G.Research reaffirmed a “buy” rating on shares of HB Fuller in a research report on Tuesday, October 8th. TheStreet raised HB Fuller from a “c+” rating to a “b-” rating in a research report on Tuesday, July 23rd. Finally, Buckingham Research set a $60.00 price objective on HB Fuller and gave the company a “buy” rating in a research report on Thursday, September 26th. Two analysts have rated the stock with a sell rating, three have issued a hold rating and three have given a buy rating to the stock. The company currently has an average rating of “Hold” and an average target price of $51.80.

Large investors have recently made changes to their positions in the business. Zions Bancorporation N.A. raised its stake in shares of HB Fuller by 6.0% during the second quarter. Zions Bancorporation N.A. now owns 4,085 shares of the specialty chemicals company’s stock worth $190,000 after buying an additional 232 shares during the last quarter. Diversified Trust Co raised its position in HB Fuller by 4.9% in the 2nd quarter. Diversified Trust Co now owns 6,400 shares of the specialty chemicals company’s stock valued at $297,000 after purchasing an additional 300 shares in the last quarter. Nisa Investment Advisors LLC raised its position in HB Fuller by 10.1% in the 2nd quarter. Nisa Investment Advisors LLC now owns 21,745 shares of the specialty chemicals company’s stock valued at $1,009,000 after purchasing an additional 2,000 shares in the last quarter. Oregon Public Employees Retirement Fund raised its position in HB Fuller by 2.5% in the 2nd quarter. Oregon Public Employees Retirement Fund now owns 20,135 shares of the specialty chemicals company’s stock valued at $934,000 after purchasing an additional 500 shares in the last quarter. Finally, Harel Insurance Investments & Financial Services Ltd. acquired a new stake in HB Fuller in the 2nd quarter valued at about $46,000. 97.48% of the stock is currently owned by institutional investors and hedge funds.

HB Fuller Company Profile

H.B. Fuller Company, together with its subsidiaries, formulates, manufactures, and markets adhesives, sealants, coatings, polymers, tapes, encapsulants, and other specialty chemical products worldwide. The company operates through five segments: Americas Adhesives, EIMEA, Asia Pacific, Construction Adhesives, and Engineering Adhesives.

Read More: Federal Reserve

Insider Buying and Selling by Quarter for HB Fuller (NYSE:FUL)

Receive News & Ratings for HB Fuller Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HB Fuller and related companies with MarketBeat.com's FREE daily email newsletter.